{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:06:45Z","timestamp":1780351605750,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","advancessurgery.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Surgery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.yasu.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:16:13Z","timestamp":1716491773000},"page":"49-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?"],"prefix":"10.1016","volume":"58","author":[{"given":"Nolan M.","family":"Winicki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.yasu.2024.04.004_bib1","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","article-title":"Colorectal cancer epidemiology: recent trends and impact on outcomes","volume":"22","author":"Baidoun","year":"2021","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.yasu.2024.04.004_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J Clin"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.yasu.2024.04.004_bib4","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1038\/srep29765","article-title":"Patterns of metastasis in colon and rectal cancer","volume":"6","author":"Riihim\u00e4ki","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.yasu.2024.04.004_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2024.04.004_bib6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"34","key":"10.1016\/j.yasu.2024.04.004_bib7","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.yasu.2024.04.004_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.23922\/jarc.2020-033","article-title":"Investigation of the Japanese Classification of Peritoneal Metastasis from Colorectal Cancer Referring to the Correlation with PCI","volume":"4","author":"Kawasaki","year":"2020","journal-title":"J\u00a0Anus Rectum Colon"},{"issue":"4","key":"10.1016\/j.yasu.2024.04.004_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.23922\/jarc.2022-045","article-title":"Molecular analyses in peritoneal metastasis from colorectal cancer: a review-an english version","volume":"6","author":"Kim","year":"2022","journal-title":"J\u00a0Anus Rectum Colon"},{"issue":"16","key":"10.1016\/j.yasu.2024.04.004_bib10","article-title":"Prognostic factors of survival in patients with peritoneal metastasis from colorectal cancer","volume":"11","author":"Mendoza-Moreno","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.yasu.2024.04.004_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41556-017-0027-6","article-title":"Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas","volume":"20","author":"Zajac","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"27","key":"10.1016\/j.yasu.2024.04.004_bib12","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: Optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.yasu.2024.04.004_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1245\/s10434-018-6462-1","article-title":"AJCC 8th edition: colorectal cancer","volume":"25","author":"Weiser","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.yasu.2024.04.004_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.yasu.2024.04.004_bib15","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1200\/JCO.2004.10.012","article-title":"Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study","volume":"22","author":"Glehen","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.yasu.2024.04.004_bib16","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11605-021-05075-1","article-title":"Prognostic significance of preoperative tumor markers in pseudomyxoma peritonei from low-grade appendiceal mucinous neoplasm: a study from the US HIPEC Collaborative","volume":"26","author":"Nizam","year":"2022","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"9","key":"10.1016\/j.yasu.2024.04.004_bib17","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1245\/s10434-020-08416-7","article-title":"Extent of peritoneal metastases on preoperative DW-MRI is predictive of disease-free and overall survival for CRS\/HIPEC candidates with colorectal cancer","volume":"27","author":"Engbersen","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12957-019-1618-4","article-title":"Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study","volume":"17","author":"Burnett","year":"2019","journal-title":"World J Surg Oncol"},{"issue":"8","key":"10.1016\/j.yasu.2024.04.004_bib19","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1245\/s10434-019-07378-9","article-title":"RAS mutation decreases overall survival after optimal cytoreductive surgery and hyperthermic intraperitoneal chemotherapy of colorectal peritoneal metastasis: a modification proposal of the peritoneal surface disease severity score","volume":"26","author":"Arjona-Sanchez","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2024.04.004_bib20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.yasu.2024.04.004_bib21","first-page":"2495131","article-title":"Prognostic relevance of the peritoneal surface disease severity score compared to the peritoneal cancer index for colorectal peritoneal carcinomatosis","volume":"2016","author":"Ng","year":"2016","journal-title":"Int J Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jso.21169","article-title":"Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis","volume":"99","author":"Pelz","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib23","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1245\/s10434-019-07294-y","article-title":"Impact of synchronous versus metachronous onset of colorectal peritoneal metastases on survival outcomes after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a multicenter, retrospective, observational study","volume":"26","author":"Hentzen","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib24","first-page":"18","article-title":"Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective","volume":"7","author":"Neuwirth","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.yasu.2024.04.004_bib26","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1245\/s10434-023-13608-y","article-title":"Prophylactic hysterectomy during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for high grade tumors is associated with fewer pelvic recurrences","volume":"30","author":"Florissi","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12893-022-01786-7","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: lessons from 20 years' experience","volume":"22","author":"Farrell","year":"2022","journal-title":"BMC Surg"},{"issue":"3","key":"10.1016\/j.yasu.2024.04.004_bib28","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/AS9.0000000000000193","article-title":"Extent of disease on visceral peritoneal surfaces of mucinous appendiceal neoplasms controls survival","volume":"3","author":"Sugarbaker","year":"2022","journal-title":"Ann Surg Open"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib29","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1245\/s10434-020-09312-w","article-title":"Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC","volume":"28","author":"Istl","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2024.04.004_bib30","article-title":"Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer","volume":"7","author":"Yurttas","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.yasu.2024.04.004_bib31","series-title":"The ASCRS Textbook of colon and rectal surgery","first-page":"605","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","author":"Valente","year":"2022"},{"key":"10.1016\/j.yasu.2024.04.004_bib32","series-title":"Unusual cases in peritoneal surface malignancies","first-page":"11","article-title":"Selection of chemotherapy in hyperthermic intraperitoneal chemotherapy","author":"Braam","year":"2017"},{"issue":"2","key":"10.1016\/j.yasu.2024.04.004_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.yasu.2024.04.004_bib34","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1016\/j.ejso.2021.05.023","article-title":"The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)","volume":"47","author":"van de Vlasakker","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4251\/wjgo.v12.i7.756","article-title":"Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative","volume":"12","author":"Leiting","year":"2020","journal-title":"World J Gastrointest Oncol"},{"issue":"3","key":"10.1016\/j.yasu.2024.04.004_bib36","doi-asserted-by":"crossref","first-page":"20190007","DOI":"10.1515\/pp-2019-0007","article-title":"Early postoperative intraperitoneal chemotherapy for lower gastrointestinal neoplasms with peritoneal metastasis: a systematic review and critical analysis","volume":"4","author":"Soucisse","year":"2019","journal-title":"Pleura and peritoneum"},{"key":"10.1016\/j.yasu.2024.04.004_bib37","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1245\/s10434-015-4914-4","article-title":"Early postoperative chemotherapy after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for isolated peritoneal carcinomatosis of colon cancer: a multicenter study","volume":"23","author":"Maillet","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12885-020-07756-7","article-title":"High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11605-019-04463-y","article-title":"Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a US HIPEC collaborative study","volume":"24","author":"Lee","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.yasu.2024.04.004_bib41","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1245\/s10434-013-3223-z","article-title":"Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database","volume":"21","author":"Bartlett","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.yasu.2024.04.004_bib42","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1245\/s10434-017-5821-7","article-title":"Major postoperative complications are a risk factor for impaired survival after CRS\/HIPEC","volume":"24","author":"Schneider","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib43","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","article-title":"Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients","volume":"57","author":"Baratti","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.yasu.2024.04.004_bib44","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s10147-019-01609-5","article-title":"High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"25","author":"Tan","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib45","doi-asserted-by":"crossref","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.yasu.2024.04.004_bib46","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1245\/s10434-016-5109-3","article-title":"Factors associated with readmission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis","volume":"23","author":"Martin","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1245\/s10434-012-2579-9","article-title":"Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk?","volume":"20","author":"Tsilimparis","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2024.04.004_bib48","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1245\/s10434-020-08443-4","article-title":"Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: early results from a prospective cohort study of 115 patients","volume":"27","author":"Steffens","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2024.04.004_bib49","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1245\/s10434-020-08379-9","article-title":"Systematic review of factors affecting quality of life after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Leimk\u00fchler","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2024.04.004_bib50","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ejso.2018.07.061","article-title":"Autopsy of an expert consensus: end of hyperthermic intraperitoneal chemotherapy in colorectal carcinomatosis","volume":"44","author":"Evrard","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib51","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12885-018-4096-0","article-title":"HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma","volume":"18","author":"Arjona-S\u00e1nchez","year":"2018","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.yasu.2024.04.004_bib53","first-page":"1404","article-title":"Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy","volume":"106","author":"Ubink","year":"2019","journal-title":"J\u00a0Br Surg"},{"key":"10.1016\/j.yasu.2024.04.004_bib54","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1245\/s10434-013-3145-9","article-title":"Cytoreduction and HIPEC in the Netherlands: nationwide long-term outcome following the Dutch protocol","volume":"20","author":"Kuijpers","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2024.04.004_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jso.26750","article-title":"Regional therapy trials in peritoneal metastases: The path to standardization of care: Introduction","volume":"125","author":"Foster","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.yasu.2024.04.004_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.critrevonc.2017.03.028","article-title":"Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review","volume":"114","author":"Rovers","year":"2017","journal-title":"Crit Rev Oncol-Hematol"},{"issue":"8","key":"10.1016\/j.yasu.2024.04.004_bib57","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamasurg.2021.1642","article-title":"Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: a phase 2 randomized clinical trial","volume":"156","author":"Rovers","year":"2021","journal-title":"JAMA Surgery"},{"issue":"11","key":"10.1016\/j.yasu.2024.04.004_bib58","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1245\/s10434-022-11699-7","article-title":"The impact of neoadjuvant chemotherapy on the surgical management of colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"29","author":"Flood","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.yasu.2024.04.004_bib59","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1245\/s10434-014-3713-7","article-title":"Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis","volume":"21","author":"Ceelen","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.yasu.2024.04.004_bib60","first-page":"55","article-title":"Perioperative chemotherapy in colorectal cancer with peritoneal metastases: a global propensity score matched study","author":"Cashin","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.yasu.2024.04.004_bib61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clcc.2018.07.011","article-title":"Perioperative systemic chemotherapy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy in patients with colorectal peritoneal metastasis: results of the prospective multicenter phase 2 COMBATAC Trial","volume":"17","author":"Glockzin","year":"2018","journal-title":"Clin Colorectal Cancer"},{"issue":"8","key":"10.1016\/j.yasu.2024.04.004_bib62","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/s00595-014-1017-y","article-title":"Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery","volume":"45","author":"Adachi","year":"2015","journal-title":"Surg Today"},{"issue":"5","key":"10.1016\/j.yasu.2024.04.004_bib63","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3181d9765d","article-title":"A\u00a0comparative study of complete cytoreductive surgery plus intraperitoneal chemotherapy to treat peritoneal dissemination from colon, rectum, small bowel, and nonpseudomyxoma appendix","volume":"251","author":"Elias","year":"2010","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.yasu.2024.04.004_bib64","doi-asserted-by":"crossref","first-page":"e202701","DOI":"10.1001\/jamaoncol.2020.2701","article-title":"Adjuvant systemic chemotherapy vs active surveillance following up-front resection of isolated synchronous colorectal peritoneal metastases","volume":"6","author":"Rovers","year":"2020","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2024.04.004_bib65","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S2468-1253(19)30239-0","article-title":"Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial","volume":"4","author":"Klaver","year":"2019","journal-title":"The lancet Gastroenterology & hepatology"},{"issue":"9","key":"10.1016\/j.yasu.2024.04.004_bib66","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP\u2013PRODIGE 15): A randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.yasu.2024.04.004_bib67","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamasurg.2023.0662","article-title":"Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer: a phase 3 randomized clinical trial","volume":"158","author":"Arjona-S\u00e1nchez","year":"2023","journal-title":"JAMA Surgery"}],"container-title":["Advances in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341124000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341124000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T02:06:03Z","timestamp":1729735563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065341124000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0065341124000046"],"URL":"https:\/\/doi.org\/10.1016\/j.yasu.2024.04.004","relation":{},"ISSN":["0065-3411"],"issn-type":[{"value":"0065-3411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?","name":"articletitle","label":"Article Title"},{"value":"Advances in Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yasu.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}